Transgenic clawed frog embryos and use thereof as detectors of endocrine disrupters in the environment
CA 2487765 C · Owner: Demeneix, Barbara · Inventors: Demeneix, Barbara; Turque, Nathalie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to transgenic aquatic animals particularly the clawed frog and the zebra fish and cells derived therefrom characterised in comprising at least one expression cassette with a regulatory DNA sequence selected from the response elements to nuclear hormone receptors particularly TRE, connected in a functional manner downstream of a DNA segment coding for a marker protein such as luciferase or GFP. The invention further relates to methods using the transgenic cells and animals according to the invention for the identification of endocrine disrupters in the environment.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed May 27, 2003 and granted December 3, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended May 27, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by May 27, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.